Does REBOXETINE Cause Salivary hypersecretion? 5 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Salivary hypersecretion have been filed in association with REBOXETINE. This represents 2.7% of all adverse event reports for REBOXETINE.
5
Reports of Salivary hypersecretion with REBOXETINE
2.7%
of all REBOXETINE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Salivary hypersecretion From REBOXETINE?
Of the 5 reports, 5 (100.0%) required hospitalization.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REBOXETINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does REBOXETINE Cause?
Hyperhidrosis (21)
Off label use (20)
Weight increased (18)
Tachycardia (17)
Confusional state (16)
Intentional overdose (16)
Nausea (16)
Drug ineffective (15)
Drug interaction (15)
Sleep disorder (15)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which REBOXETINE Alternatives Have Lower Salivary hypersecretion Risk?
REBOXETINE vs RECLAST
REBOXETINE vs RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E
REBOXETINE vs REGADENOSON
REBOXETINE vs REGORAFENIB
REBOXETINE vs REGORAFENIB\REGORAFENIB